Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study

Maturity-onset diabetes of the young (MODY) is a grouping of monogenic disorders. It is characterized by dominantly inherited, non-insulin-dependent diabetes. MODY is relatively rare, encompassing up to 3.5% in those diagnosed under 30 years of age. Specific types are most commonly treated with sulf...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Angham Almutair, Beshaier Almulhem
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Subjects:	HNF1B-MODY semaglutide successful MODY GLP-1RA
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1294264/full